Clinical trial
S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced…
NCT00026156 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00026156 |
|---|---|
| Title | S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cell Lung Cancer Patients Age Seventy and Older, or With Performance Status 2 |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, vinorelbine tartrate |
| Enrollment | 125 |
| Start date | Nov 1, 2001 |
| Primary completion | Jul 1, 2004 |
| Completion | Nov 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 15, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: